HomeLung cancer screening

Lung cancer screening

    H. Prosch

    The identification of an effective diagnostic tool for the early detection of pulmonary malignancies in high-risk populations has become a top priority as it is frequently diagnosed in advanced stages of the disease, leading to dramatically high mortality rates.
    In this videographic, Prof. Prosch looks at the recent advancements in lung cancer screening made possible by the validation, standardization, and recommendation of low-dose CT by many large-scale international clinical studies and confirmed in daily clinical practice. This videographic, which accompanies Prof. Prosch’s talk, sheds light on the specific high-risk groups that can benefit from low-dose CT for lung cancer screening; it also outlines specific protocols designed to optimize the interpretation and reporting of findings and emphasizes the substantial reduction in mortality achieved with this imaging approach, underscoring its fundamental impact in daily clinical practice.